These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35462965)

  • 1. 'Beyond' Human Enhancement - Taking the Developing Country's Perspective Seriously.
    Sachdev V
    Asian Bioeth Rev; 2022 Apr; 14(2):169-182. PubMed ID: 35462965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human enhancement and supra-personal moral status.
    Douglas T
    Philos Stud; 2013 Feb; 162(3):473-497. PubMed ID: 23576821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomedical Enhancement and Social Development: A Conservative Techno-Fix.
    Sanyal S
    Bioethics; 2016 Nov; 30(9):733-740. PubMed ID: 27666727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing the health care market in developing countries: prospects and problems.
    Broomberg J
    Health Policy Plan; 1994 Sep; 9(3):237-51. PubMed ID: 10137740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic enhancement, post-persons and moral status: a reply to Buchanan.
    DeGrazia D
    J Med Ethics; 2012 Mar; 38(3):135-9. PubMed ID: 22074771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Social and Ethical Acceptability of NBICs for Purposes of Human Enhancement: Why Does the Debate Remain Mired in Impasse?
    Béland JP; Patenaude J; Legault GA; Boissy P; Parent M
    Nanoethics; 2011 Dec; 5(3):295-307. PubMed ID: 22247747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The silencing of Kierkegaard in Habermas' critique of genetic enhancement.
    Christiansen K
    Med Health Care Philos; 2009 Jun; 12(2):147-56. PubMed ID: 19234761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strengthening cost-effectiveness analysis in Thailand through the establishment of the health intervention and technology assessment program.
    Tantivess S; Teerawattananon Y; Mills A
    Pharmacoeconomics; 2009; 27(11):931-45. PubMed ID: 19888793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autonomy, natality and freedom: a liberal re-examination of Habermas in the enhancement debate.
    Pugh J
    Bioethics; 2015 Mar; 29(3):145-52. PubMed ID: 24547807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MEDICAL SCIENCE, RESEARCH AND HIGHER EDUCATION IN AZERBAIJAN FROM BIOETHICAL DEVELOPMENTS PERSPECTIVE.
    Vugar M; Kerim M; Lala J
    Med Pravo; 2016; 2(18):18-43. PubMed ID: 28409020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population education in the school curriculum: a comparative analysis of the American and Asian models.
    Okobiah OS
    Comp Educ Rev; 1981 Feb; 25(1):64-73. PubMed ID: 12267790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moral philosophy and public policy: the case of NRTs.
    Kymlicka W
    Bioethics; 1993 Jan; 7(1):1-26. PubMed ID: 11654026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The uses of modern technologies: problems and perspectives for industrialized and developing countries.
    Banta D
    Bull Pan Am Health Organ; 1984; 18(2):139-50. PubMed ID: 6487871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promotion of research in human reproduction: global needs and perspectives.
    Fathalla MF
    Hum Reprod; 1988 Jan; 3(1):7-10. PubMed ID: 3350938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioethics and the reinforcement of socio-technical expectations.
    Hedgecoe A
    Soc Stud Sci; 2010 Apr; 40(2):163-86. PubMed ID: 20527320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Authorship ethics in global health research partnerships between researchers from low or middle income countries and high income countries.
    Smith E; Hunt M; Master Z
    BMC Med Ethics; 2014 May; 15():42. PubMed ID: 24885855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What are we to make of the charge that human biological enhancement technologies are 'unnatural'?
    Miller PR
    J Med Ethics; 2019 Feb; 45(2):140-143. PubMed ID: 30076200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing data availability for the development of REDD-plus national reference levels.
    Umemiya C; Amano M; Wilamart S
    Carbon Balance Manag; 2010 Sep; 5():6. PubMed ID: 20920279
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.